PITTSBURGH, Dec. 19 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. announced today that the regular quarterly cash dividend of $.06 per share will be payable on January 16, 2007, to shareholders of record at the close of business on December 29, 2006.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products.
For more information about Mylan, please visit www.mylan.com.
Mylan Laboratories Inc.CONTACT: Patrick Fitzgerald or Kris King, both of Mylan Laboratories Inc.,+1-724-514-1800
Web site: http://www.mylan.com/
